Costing analysis of national HIV treatment and care program in Vietnam

Abstract

The study found that HIV treatment and care costs in Vietnam are economical, yet there is potential to further promote efficiency through strengthening competitive procurement, integrating HIV services, and promoting earlier antiretroviral therapy (ART) initiation. Non-antiretroviral (ARV) costs in adults at stand-alone facilities were 44% (first year ART) and 24% (later year ART) higher than those at integrated facilities. As well, early treatment before patients’ progress to advanced immunodeficiency will prevent an increase in new HIV infections, while decreasing need for ART in the future. This study provides a first-ever evidence base for nationwide HIV treatment and care costs in Vietnam.

Description

Keywords

ANTIRETROVIRAL THERAPY, HIV/AIDS, COST ANALYSIS, INTEGRATION, VIET NAM, ACCESS TO HEALTH CARE, HEALTH-CARE DELIVERY, NATIONAL SERVICE FRAMEWORK, COST ANALYSIS, ECONOMETRICS

Citation

Anh Thuy Duong, Kato, M., Bales, S., Nhan Thi Do, Thu Thi Minh Nguyen, Thuy Thi Thanh Cao, et al. (2014). Costing Analysis of National HIV Treatment and Care Program in Vietnam. JAIDS Journal of Acquired Immune Deficiency Syndromes, 65(1), e1-e7. doi:10.1097/QAI.0b013e3182a17d15

DOI